L eishmania major infection in mice has proven to be a powerful model to dissect the immune processes that govern polarized Th1/Th2 cytokine responses. In susceptible BALB/c mice, an early burst of IL-4 after L. major infection drives Th2 polarization, impairs Th1 responses required for parasite elimination, and finally leads to fatal disease (1) . In addition to IL-4, the related cytokine IL-13 has been also demonstrated as a factor for L. major susceptibility (2, 3) . Based on this evidence, IL-4/ IL-13 signaling through the shared IL-4R ␣-chain (IL-4R␣) is considered to play a pivotal role in L. major susceptibility.
Inconsistent with the Th1/Th2 paradigm, BALB/c IL-4 Ϫ/Ϫ and IL-4R␣ Ϫ/Ϫ mice failed to control parasite growth of certain L. major substrains such as LV39 (2, 4) and NIH/Seidman (5), whereas IL-4R␣ Ϫ/Ϫ mice controlled other L. major substrains, including IR173 and V1 (2) . These data imply the existence of additional or alternative pathways for L. major disease progression in BALB/c mice.
Results from a number of groups now support the concept that IL-10 is an important susceptibility factor for L. major. In a previous report, we have shown that both IL-10 and IL-4R␣ signaling contribute to L. major susceptibility regardless of L. major substrains (6) . In addition, Kane and Mosser (7) demonstrated fewer L. major parasites in IL-10 Ϫ/Ϫ mice on a susceptible BALB/c background. Moreover, in resistant C57BL/6 mice, IL-10 has been shown to be involved in maintaining a persistent L. major infection that may be required for maintaining immunological memory (8) .
CD4 ϩ CD25 ϩ T regulatory (Treg) 4 cells control several autoimmune diseases via cell-cell interactions and soluble factors such as IL-10 and TGF-␤ (9, 10) . Within the CD4 ϩ
CD25
ϩ Treg population, further classifications differentiate naturally occurring, thymic-derived Treg cells that express the transcription factor Foxp3 (11) , and those that have been induced in the periphery via APC interactions, the cytokine milieu, or that are induced by the natural Treg population (12) (13) (14) (15) (16) .
Several groups have explored the role of Treg cells in L. major infection. In resistant mice, IL-10 secretion from Treg cells was necessary for L. major substrain V1 parasite persistence following clinical cure in C57BL/6 mice (17) . CD4 ϩ CD45RB low T cells, which are enriched for CD4 ϩ CD25 ϩ Treg cells, have been shown to cause susceptibility after transfer into SCID mice (18) . In addition, Treg cells were shown to suppress both Th1 and Th2 differentiation early in L. major infection (19) , but ultimately caused disease later in infection via secretion of several factors, including . Contrary to these findings, Aseffa et al. (21) reported that Treg cells protect against L. major infection, and that disease severity in susceptible BALB/c mice was exacerbated after depleting CD4 ϩ CD25 ϩ Treg cells in vivo. In recent studies using bicistronic Foxp3 reporter mice, Anderson et al. (22) have shown that the nonhealing phenotype in C57BL/6 mice infected with L. major Seidman is due to IL-10 secretion from CD4 ϩ
Ϫ Foxp3 Ϫ T cells. Thus, the role of CD4 ϩ CD25 ϩ Treg cells in susceptibility to L. major infection, particularly in BALB/c mice, remains unresolved.
In the study presented in this work, we evaluated the role of Treg cells in L. major in susceptible IL-4R␣-deficient mice, which, in the absence of IL-4/IL-13 signaling, remain highly susceptible to L. major substrain LV39 due to IL-10. We used both the conventional footpad infection as well as the ear dermal infection model (23) , which allows analysis of events occurring within the site of infection. Because IL-10 is the exclusive cytokine mediating susceptibility in IL-4R␣
Ϫ/Ϫ mice, we have the opportunity to dissect the conditions and the cells that invoke IL-10 responses to L. major infection in vivo.
Materials and Methods

Mice
Genetically pure BALB/c IL-4R␣ Ϫ/Ϫ mice were generated, as previously described (24) . BALB/c IL-10 Ϫ/Ϫ mice (backcross n ϭ 8) were provided by D. Rennick (DNAX Research Institute, Palo Alto, CA) and bred in our facility. IL-4R␣ ϫ IL-10 and IL-4R␣ ϫ RAG2 double-deficient mice were generated by crossing the parental strains and maintained under contract at Taconic Farms. All mice were maintained under specific pathogen-free conditions in the George Washington University Medical Center under protocols approved by the Institutional Animal Care and Use Committee.
Culture medium
Complete RPMI 1640 consisted of RPMI 1640 medium (Mediatech) supplemented with 10% FBS (Invitrogen Life Technologies), 1 mM sodium pyruvate, 2 mM L-glutamine, 0.05 M 2-ME, 100 U/ml penicillin, and 100 g/ml streptomycin.
Parasites
L. major substrain LV39 (MRHO/SU/59/P) promastigotes (pm) were cultured at 26°C in medium 199 supplemented with 20% heat-inactivated FCS (Gemini Bio-Products), 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, 40 mM HEPES, 0.1 mM adenine, and 5 g/ml hemin (M199/S). Infective stage metacyclic pm were isolated from stationary culture (5-7 days old) by Ficoll (FisherBiotec) density gradient method, as described previously (25) . Mice were infected s.c. with 10 5 purified metacyclics in the left hind footpad or with 2 ϫ 10 4 metacyclics intradermally in the ear dermis, as previously described (23) .
Parasite quantitation
Infected footpad tissue homogenates were prepared by using Teflon-coated microtissue grinder in 1.5-ml microfuge tubes containing 200 l of M199/S. Homogenates were serially diluted in a 96-well flat-bottom microtiter plate containing 50 l of rabbit blood agar (1.4% agar of NovyMacNeal-Nicolle medium containing 30% defibrinated rabbit blood). One well was used for each 2-fold serial dilution. The number of viable parasites in each sample was determined from the highest dilution at which pm could be detected after 10 days of incubation at 26°C. Parasite numbers in the ear dermis were determined, as previously described (17) . Briefly, the ventral and dorsal sheets of the infected ears were separated; deposited dermal-side down in DMEM containing 100 U/ml penicillin, 100 g/ml streptomycin, and 50 g/ml Liberase CI enzyme blend (Roche Diagnostic Systems); incubated for 2 h at 37°C; and homogenized using a MediMachine (DakoCytomation). The resultant ear homogenates were filtered using a 70-m pore-size cell strainer (Filcon Products) to exclude debris. Right and left ears were pooled for each individual mouse, and parasite numbers were calculated by dividing the total pm by two. The numbers of parasites in the local draining lymph nodes (LN; popliteal or retromaxillar) were also determined. The LN were removed, mechanically dissociated, and serially diluted in the rabbit blood agar plates, as described above.
In vitro stimulation and ELISAs
To measure Leishmania-specific cytokine responses, 6 ϫ 10 5 draining LN cells were cultured in 96-well plates with 200 l of complete RPMI 1640 containing 25 g/ml soluble Leishmania Ags (SLA) prepared from LV39 metacyclic pm. Supernatants were harvested at 72 h after stimulation and assayed for cytokines. IFN-␥ (Pierce) and IL-10 (R&D Systems) ELISAs were performed, according to manufacturers' instructions.
Antibodies
Anti-CD4-PerCP, -FITC; CyChrome (RM4-5); anti-CD25-PE, -allophycocyanin (3C7 and PC61); anti-IL-10-PE, -allophycocyanin (JES5-16E3); anti-IFN-␥-FITC, -allophycocyanin (XMG1.2); anti-IL-4-PE (11B11); and anti-CD103 (M290) were all purchased from BD Biosciences. The 3C7 and PC61 mAb recognize distinct epitopes on the CD25 molecule. Anti-Foxp3 (FJK-16s) labeled with FITC and PE was purchased from eBioscience. The anti-CD25 hybridoma (PC61.5.3, rat IgG1) was purchased from American Type Culture Collection. Anti-IL-10R (1B1.3a, rat IgG1) and control mAb (GL113, rat IgG1) hybridomas were provided by K. Moore (DNAX, Palo Alto, CA). The anti-CD25, anti-IL-10R, and control mAbs used in vivo were generated from ascites produced in nude mice and purified by ammonium sulfate precipitation and ion exchange chromatography (Harlan Bioproducts). 
T cell transfers
T cell stimulation and intracellular staining
Ear dermal homogenates were cultured overnight at 37°C in 600 l of complete RPMI 1640 in 48-well plates. The next day, the cells were stimulated with 10 ng/ml PMA and 500 ng/ml ionomycin in the presence of 3 mM monensin (BD Biosciences) for 4 h. Cells were washed; blocked with 5% normal mouse serum and 2.4G2 (10 g/ml), stained with cell surface markers, including anti-CD4 CyChrome, anti-CD25 allophycocyanin, and/or anti-CD103 FITC; and then cells were washed and fixed in 1ϫ Fix/Perm solution for Foxp3 intranuclear staining for 1 h on ice or Cytofix/ CytoPerm for 15 min for all other intracellular staining. The cells were washed and resuspended in permeabilization buffer (BD Biosciences or eBioscience), and then stained with combinations of anti-IFN-␥ FITC, anti-IL-10 PE, or anti-Foxp3 FITC, and analyzed by FACS. For each sample, 300,000 total events were analyzed. The data were collected and analyzed using CellQuest software and a FACSCalibur flow cytometer or FACSDiva software and a FACSAria flow cytometer (BD Biosciences).
Quantitative RT-PCR
Total RNA was extracted from FACS-sorted CD4 ϩ populations from BALB/c and IL-4R␣ ear dermis homogenates using the RNeasy micro kit (Qiagen). The sorted populations were
One hundred nanograms (Fig. 7B , Expt. 1) or 5 ng (Fig. 7B, Expt. 2) of total RNA of each sample was reverse transcribed into cDNA by Superscript III first-strand synthesis kit (Invitrogen Life Technologies) and random hexamer primers, according to the manufacturer's instruction. The resultant cDNA was analyzed for the expression of Foxp3, IL-10, IFN-␥, and 18S rRNA using TaqMan Universal PCR Master Mix and Gene Expression Assay Mix (Applied Biosystems). Samples were amplified using the ABI Real-Time System (Applied Biosystems) or the Chromo4 Four-Color Real-Time PCR Detector (MJ Research; Bio-Rad). Sample cycle threshold (C T ) values were standardized to 18S rRNA values. The adjusted values were calculated based on the formula: 2 Ϫ(CT target -CT 18S) (26) .
Statistical analysis
Statistical analysis for parasite numbers and cytokine values was performed using GraphPad Prism software and Student's t test at 95% confidence intervals, with differences considered significant at ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01; and ‫,ءءء‬ p Ͻ 0.001.
Results
IL-4R␣
Ϫ/Ϫ mice remain susceptible to L. major LV39 in footpad and ear dermis injection sites
We have established that genetically pure BALB/c IL-4R␣-deficient mice are highly susceptible to s.c. footpad injection of 10 5 infectious metacyclics of L. major substrain LV39. To investigate the mechanisms of L. major susceptibility within the site of infection, we used the ear dermal infection model initially described by Belkaid et al. (23) . As shown in Fig. 1A , at day 48 postinfection, infected IL-4R␣ Ϫ/Ϫ mice were as susceptible as BALB/c mice with respect to parasite numbers in the footpad (pm/mg tissue), or infected ear dermis (total parasites/ear). Equivalent parasite numbers were also observed in the draining LN in both models of infection in IL-4R␣ Ϫ/Ϫ and BALB/c mice (data not shown). These results confirm that IL-4R␣ Ϫ/Ϫ mice remain susceptible to L. major LV39, regardless of the infection site, and both models can be useful for evaluating the mechanisms of L. major susceptibility in the absence of IL-4/IL-13 signaling.
We have previously shown that IL-4R␣ Ϫ/Ϫ mice, while maintaining high numbers of parasites, had depressed levels of L. major-specific Th2 cytokines, including IL-10. In contrast to what would be predicted based on the Th1/Th2 paradigm, IL-4R␣ Ϫ/Ϫ mice did not default to a robust Th1 response with increased IFN-␥ secretion (2) . Fig. 1B shows that draining LN cells from IL-4R␣ Ϫ/Ϫ ear dermis infections (bottom panel) displayed similar trends and IFN-␥ levels were not significantly elevated.
Although IL-10 secretion was somewhat increased in the IL-4R␣ Ϫ/Ϫ ear dermis draining LN after ex vivo SLA stimulation, the amounts of IL-10 were not statistically different from BALB/c levels. Therefore, the patterns of parasite growth and cytokine secretion are maintained in the ear dermis model of infection and can be used to dissect the cells and mechanisms promoting L. major susceptibility.
In vivo CD25 depletion partially controls L. major infection in IL-4R␣
Ϫ/Ϫ mice
We next examined the cellular source of IL-10 secretion in L.
ϩ T cells with a regulatory function have been shown to secrete IL-10 in both L. major-resistant and -susceptible mice (17, 20) . We addressed the role of Treg cells in causing L. major susceptibility in IL-4R␣ Ϫ/Ϫ mice by in vivo depletion of Treg cells using anti-CD25 mAb and adoptive transfer of CD25-depleted T cell populations into IL-4R ϫ RAG2 recipients.
BALB/c, IL-4R␣ Ϫ/Ϫ , and IL-10 Ϫ/Ϫ mice were given weekly injections of either anti-CD25 mAb (clone PC61.5.3) or anti-IL-10R mAb (clone 1B1.3a) during L. major infection, and parasite numbers were quantitated in the footpad and ear dermis (Fig. 2) . If CD4 ϩ CD25 ϩ T cells are the primary producers of IL-10, both anti-CD25 and anti-IL-10R treatments should lead to similar reductions in parasites in IL-4R␣ Ϫ/Ϫ mice. After anti-IL-10R treatment, IL-4R␣ Ϫ/Ϫ mice were highly resistant to both footpad and dermal infections and contained Ϸ10,000-to 15,000-fold fewer L. major parasites than controls. Several IL-4R␣ Ϫ/Ϫ mice harbored no detectable parasites after 6-wk infection (Fig. 2) . In parallel infections, BALB/c mice treated with anti-IL-10R showed some control of L. major growth with Ϸ40-and Ϸ700-fold decreases in footpad and ear dermis infection sites, respectively. Interestingly, BALB/c IL-10 Ϫ/Ϫ mice, which are resistant to L. major Friedlin strain (7), had only marginal reductions in L. major LV39 parasite numbers ( p Ͻ 0.05 in dermal infection) and did not approach the highly resistant phenotype of anti-IL-10R-treated IL-4R␣ Ϫ/Ϫ mice ( p Ͻ 0.001). 
Taken together, comparisons of anti-IL-10R-treated BALB/c and IL-4R␣
Ϫ/Ϫ mice along with IL-10 Ϫ/Ϫ mice indicate that, regardless of the infection site, the full continuum of IL-10 and IL-4/IL-13 cytokines is involved in L. major LV39 susceptibility in BALB/c mice. These results also confirm that in the absence of IL-4/IL-13 signaling, susceptibility to L. major LV39 is mediated by IL-10, and resolution of the infection is induced by blocking IL-10R binding.
Although anti-IL-10R mAb was highly effective in reducing parasite numbers in IL-4R␣ Ϫ/Ϫ mice, anti-CD25 mAb treatments did not achieve as impressive results, but did induce a significant 460-fold decrease in the footpad ( p Ͻ 0.001) and 30-fold in the dermis ( p Ͻ 0.05) (Fig. 2) . In BALB/c mice, anti-CD25 produced only a 40-fold decrease of parasites in the footpad and 15-fold decrease in the dermis. The regimen of anti-CD25 mAb given in vivo was sufficient to deplete Ϸ90% of the CD4 ϩ CD25 ϩ population, as measured by the inhibition of labeled PC61 mAb binding on LN and ear dermal cells taken 6 wk after L. major infection and 1 wk after the final anti-CD25 injection (data not shown). In addition, a recent publication shows that anti-CD25 mAb binding will effectively block Treg suppressor function and the capacity to bind IL-2 (27) .
In contrast with our results, Aseffa et al. (21) demonstrated control of parasite growth in BALB/c mice treated with a single dose of 1 mg of anti-CD25 mAb 3 days before L. major infection. We compared both single-and multiple-dose anti-CD25 protocols in L.
major-infected BALB/c and IL-4R␣
Ϫ/Ϫ mice. Although parasite numbers in IL-4R␣ Ϫ/Ϫ mice were decreased by multiple injections of anti-CD25 similar to those in Fig. 2 , there was no change in the parasite burden of IL-4R␣ Ϫ/Ϫ mice treated with a single dose of anti-CD25 mAb (data not shown).
Because CD25 functions as the IL-2R ␣-chain, anti-CD25 mAb may, in addition to altering Treg function, block the in vivo development of effector T cells that may either protect (Th1) or exacerbate (Th2) L. major disease progression. To address whether anti-CD25 mAb affects disease outcome independently of IL-10 secretion, we depleted CD25 ϩ T cells in BALB/c IL-10 Ϫ/Ϫ mice. Fig. 2 shows that anti-CD25-treated IL-10 Ϫ/Ϫ mice contained 60-fold fewer parasites in the footpad lesions ( p Ͻ 0.05), implying that anti-CD25 somewhat impedes the development of effector T cells, presumably IL-4-and IL-13-producing Th2 cells.
With regard to cytokine patterns, IFN-␥ secretion was a more reliable indicator of successful parasite clearance in footpad infections than in the dermis model (Fig. 3) . Footpad-infected IL-4R␣ Ϫ/Ϫ mice had pronounced IFN-␥ levels after both anti-CD25 and anti-IL-10R treatments (Fig. 3A) . Anti-CD25 also induced an IFN-␥ response in IL-10 Ϫ/Ϫ mice, suggesting that, along with IL-10-secreting Treg cells, a portion of the CD4 ϩ CD25 ϩ T population includes IL-4-or IL-13-secreting effector Th2 cells during L. major infection. We did not find statistical differences in the levels of IFN-␥ in SLA-stimulated ear dermis LN cells (Fig. 3B) .
As shown in Fig. 3 , in both SLA-stimulated footpad and ear dermis LN populations, anti-IL-10R mAb-treated IL-4R␣ Ϫ/Ϫ mice showed a significant decrease in IL-10 secretion compared with CD25 depletion ( p Ͻ 0.05 for footpad LN and p Ͻ 0.01 for dermal LN). Dermal LN cultures from anti-IL-10R mAb-treated IL-4R␣ Ϫ/Ϫ mice were also significantly reduced in IL-10 production compared with LN from anti-CD25 mAb mice ( p Ͻ 0.05). Taken together, the data from the two infection models show that whereas blocking IL-10 activity is sufficient to resolve L. major infection in IL-4R␣
Ϫ/Ϫ mice, depletion of CD4 ϩ CD25 ϩ T cells in vivo does not induce a similar resistant phenotype. This implies that CD4 ϩ
CD25
ϩ T cells may be only a partial source of IL-10 in L. major LV39 susceptibility and indicate the existence of other sources of IL-10 that contribute to L. major parasite survival.
Adoptive transfer of CD4
We next asked whether transferring CD25-depleted T cells (CD4 ϩ CD25 Ϫ ) into IL-4R ϫ RAG2 recipients would induce a resistant phenotype. In order to maintain susceptibility to L. major in IL-4R␣ ϫ RAG2-reconstituted mice, it was necessary to transfer a high dose of T cells. Varkila et al. (28) have shown that adoptive transfer of low numbers of T cells causes a healing phenotype in BALB/c SCID mice, whereas a high-dose (7.5 ϫ 10 7 ) transfer of splenocytes leads to susceptibility. We therefore transferred 1 ϫ 10 7 total naive CD4 ϩ T cells from either IL-4R␣ Ϫ/Ϫ or IL-4R␣ ϫ IL-10 double-knockout (KO) mice and compared these with mice reconstituted with 1 ϫ 10 7 CD4 ϩ CD25 Ϫ -purified cells from IL-4R␣ Ϫ/Ϫ mice. The reconstituted recipients were infected with L. major LV39, and parasite burdens were compared with intact susceptible BALB/c, IL-4R␣ Ϫ/Ϫ , and IL-10 Ϫ/Ϫ mice and resistant IL-4R␣ ϫ IL-10 KO mice (Fig. 4) .
As expected, the nonreconstituted IL-4R␣ ϫ RAG2 mice had uncontrolled infections and contained high numbers of parasites in the ear dermis 6 wk postinfection (Fig. 4) . Reconstitution of the IL-4R␣ ϫ RAG2 mice with total CD4 cells from either IL-4R␣ Ϫ/Ϫ or IL-4R␣ ϫ IL-10 KO mice restored the respective phenotypes observed in the intact susceptible and resistant mouse strains.
More importantly, mice reconstituted with 1 ϫ 10 7 CD4
ϩ CD25 Ϫ T cells were not resistant, and had comparable parasite numbers in the ear dermis to mice reconstituted with total CD4 ϩ T cells. Although this may suggest CD4
ϩ CD25 Ϫ T cells as a source of IL-10, it is also possible that CD25-negative Treg cells Nevertheless, an important conclusion that can be drawn from the results in Fig. 4 is that IL-10 secretion during L. major infection is primarily from T cells, as indicated by comparable parasite numbers between intact, resistant IL-4R␣ ϫ IL-10 mice and the recipient mice receiving IL-4R␣ ϫ IL-10 KO CD4 ϩ T cells. Although we cannot discount IL-10 from non-T cell sources such as macrophages, dendritic cells, or B cells, clearly a T cell source of IL-10 is playing a predominant role in L. major susceptibility. Table I ).
Increased
In contrast to the draining LN populations, the percentage of CD4 ϩ CD25 ϩ cells within the dermal infection site was increased 1.5-to 2-fold in IL-4R␣ Ϫ/Ϫ mice ( Fig. 5A and Table I ). Although we were not able to count absolute numbers of lymphocytes in these dermal cell preparations, the Ϸ4-fold increased Fig. 5 , B and C). As with CD25 expression, the increased Foxp3 expression was observed within the dermal infection site, but not in the draining LN. In addition to Foxp3, all the populations of CD4 ϩ CD25 ϩ T cells that were analyzed, regardless of their location, expressed glucocorticoid-induced TNFR (30, 31) and CD103 (32) , supporting a characteristic Treg phenotype (data not shown).
The apparent retention or accumulation of CD4 ϩ Foxp3 ϩ cells in the infection site was more closely associated with the parasite load, rather than the absence of IL-4R␣. In highly resistant IL-4R␣ ϫ IL-10 KO mice, the percentage of CD4 ϩ Foxp3 ϩ cells was remarkably low (8.4%) compared with IL-4R␣ Ϫ/Ϫ mice, or even with BALB/c mice (Fig. 5, B and C) . The absence of all susceptibility pathways (IL-4/IL-13 and IL-10) in these mice permits efficient parasite killing by infected macrophages (Fig. 4) . Ϫ/Ϫ -infected ear dermis was not increased compared with BALB/c mice (Fig. 6A) . Moreover, the majority of IL-10 was not produced by CD4 Fig. 6A ). In the retromaxillar draining LN of both BALB/c and IL-4R␣ Ϫ/Ϫ mice, IL-10 was also produced primarily by CD4
IL-10 secretion from CD4
ϩ Foxp3 Ϫ cells (data not shown). In the same analysis, CD4
ϩ cells secreting IL-10 and IFN-␥ were highly compartmentalized, with few cells producing both cytokines simultaneously (Fig. 6A, bottom panel) . These data suggest that the IL-10-producing CD4 ϩ Foxp3 Ϫ cells are distinct from the IL-10/IFN-␥-secreting Th1 cells that have recently been described in L. major-infected C57BL/6 mice (22) .
More striking was the depressed IFN-␥ response in the IL-4R␣ Ϫ/Ϫ ear dermis, with only 8.2% of the CD4 ϩ T cells expressing IFN-␥ compared with 21.4% in the BALB/c dermis (Fig. 6A,  bottom panel) . This was also true, to a lesser extent, for the IFN-␥ levels in supernatants of SLA-stimulated LN cells (Fig. 3) , but not in PMA/ionomycin-stimulated LN cells (data not shown). In a separate experiment, CD4 ϩ T cells in individual mouse ear dermis homogenates were analyzed for IL-10 and IFN-␥ production (Fig.  6B) . These results were also consistent with IL-10 secretion predominately from CD4
ϩ Foxp3 Ϫ cells, and a suppressed IFN-␥ response in the IL-4R␣ Ϫ/Ϫ -infected dermis. A possible correlation of increased CD4 ϩ Foxp3 ϩ Treg cells with suppressed IFN-␥ responses is yet speculative. In highly resistant IL-4R␣ ϫ IL-10 KO mice, dermal IFN-␥ production was not significantly increased compared with susceptible IL-4R␣ single-deficient mice (Fig. 6C) . However, this may be due to lack of L. major Ag stimulation and low numbers of inflammatory cells within the IL-4R␣ ϫ IL-10 KO dermis at 5-to 6-wk infection, when the lesions have resolved.
We next sorted CD4 ϩ T cells isolated from the ear dermis based on cell surface CD4, CD25, and CD103 expression, and used realtime quantitative PCR (qPCR) to measure Foxp3, IL-10, and IFN-␥ mRNA expression (Fig. 7) . The expression of CD103, the ␣ E ␤ 7 integrin, has been shown to accurately identify Treg subsets that may be CD4 ϩ CD25 ϩ or CD4 ϩ CD25 Ϫ , but express Foxp3 (32-34). The FACS-sort gated populations are shown in Fig. 7A . All populations were sorted to greater than 95% purity.
The qPCR results confirmed the cytokine and Foxp3 expression data obtained by intracellular staining and FACS. After L. major infection, both BALB/c and IL-4R␣ Ϫ/Ϫ mice had ϳ50-fold relative increases compared with uninfected controls in Foxp3 and IL-10 gene expression in the total ear dermis (data not shown). In mRNA isolated from highly purified CD4 ϩ T cell populations from the ear dermis, the majority of Foxp3 expression was contained within the CD25 ϩ CD103 ϩ populations, and was enriched Ϸ3-to 67-fold in BALB/c and IL-4R␣ Ϫ/Ϫ mice compared with the CD25-negative populations (Fig. 7B, Expts. 1 and 2) .
Interestingly, the qPCR profiles revealed similar levels of IL-10 mRNA expression between the CD25 ϩ CD103 ϩ and CD25 Ϫ CD103 Ϫ populations. Although these results may appear to be discordant with the FACS data shown in Fig. 6 , the percentages of IL-10-secreting cells within the respective CD4 ϩ Foxp3 Ϫ and CD4 ϩ Foxp3 ϩ populations are comparable (Fig. 6A) , and therefore the IL-10 qPCR results from sorted CD4 ϩ populations are consistent with the FACS expression data.
With regard to IFN-␥ levels, the mRNA expression was confined to the CD4 ϩ CD25 Ϫ CD103 Ϫ population, indicating that IFN-␥ expression is predominantly from the Foxp3 Ϫ and presumably, non-Treg cells, which we also observed by intracellular FACS analysis. The qPCR results also revealed suppressed IFN-␥ mRNA levels in IL-4R␣
Ϫ cells, which were 1.5-to 4-fold decreased compared with the BALB/c population (Fig. 7B) .
IL-4 secretion was not detected in the ear dermis
We next assessed the nature of the IL-10-secreting CD4
ϩ Foxp3 Ϫ population in the ear dermis and whether they are conventional Th2 cells as measured by their capacity to also secrete IL-4. As shown in Fig. 8 , there were low, but detectable numbers of CD4 ϩ cells producing IL-4 in the BALB/c retromaxillar draining LN (top Ϫ/Ϫ mice were FACS sorted based on the expression of CD25 and CD103. All populations were sorted to Ͼ95% purity, and the CD25 Ϫ
CD103
Ϫ populations were Ͼ99% pure. B, Total RNA was extracted from FACS-sorted CD4 ϩ cells based on expression of CD25 and CD103. The sorted populations from both L. major-infected BALB/c and IL-4R␣ Ϫ/Ϫ mice were reverse transcribed into cDNA, as described in Materials and Methods. cDNA was subjected to real-time qPCR using the TaqMan Probe system and Foxp3, IL-10, and IFN-␥ primers and probes. Target values were normalized to 18S rRNA expression, and the relative values were calculated based on the ⌬C T method, as described in Materials and Methods (26) . The qPCR results from two independent experimental infections are shown.
FIGURE 8. IL-10-producing CD4
ϩ cells in L. majorinfected dermis do not secrete IL-4. Groups of BALB/c, IL-4R␣, and IL-4R␣ ϫ IL-10 KO mice were infected for 5 wk with L. major LV39. Retromaxillar LN and ear dermis homogenates from infected mice were stimulated with 10 ng/ml PMA, 500 ng/ml ionomycin, and 3 mM monensin for 4 h. Retromaxillar LN from the infected groups of mice (4 -5 mice per group) were individually analyzed for IL-10 and IL-4 production. Representative FACS profiles shown were gated on CD4 ϩ cells obtained from 100,000 total accumulated events using the FACSCalibur and CellQuest analysis software. The percentage Ϯ SD of IL-10 and IL-4 single producers and IL-10/IL-4 doubleproducing CD4 ϩ T cells from individual analyzed LN is shown. Stimulated ear dermis homogenates from each group were pooled (n ϭ 10 ears), and CD4 ϩ T cells were analyzed for IL-10 and IL-4 production. Live gate was drawn on CD4-PerCP-stained cells vs side scatter, and at least 200,000 events were collected using the FACSAria. Data were analyzed using FACSDiva software. MiCK-2 cells (BD Biosciences) were used as cytokine-staining controls. The results shown represent one of three experiments.
panel) with very few IL-10/IL-4 double producers. In the ear dermis, IL-4 was not detectable in three separate infections (Fig. 8,  bottom panel) . The extremely low frequency of IL-4-producing CD4 ϩ T cells in the ear dermis infection precludes a definitive characterization of the IL-10-secreting CD4 ϩ
Foxp3
Ϫ cells as Th2 cells. Under the same stimulation and culture conditions, IL-10 and particularly robust IFN-␥ production was observed (Fig. 6) . qPCR measurements of the Th2-specific transcription factor GATA3 in CD25 ϩ/Ϫ -and CD103 ϩ/Ϫ -sorted populations were also inconclusive, because GATA3 was expressed in all sorted CD4 ϩ populations from BALB/c and IL-4R␣ Ϫ/Ϫ dermis and LN (data not shown).
Discussion
Initially grouped within IL-4-driven Th2 cytokine responses, there is growing appreciation for an autonomous role of IL-10 in L. major infection. In mouse models of leishmaniasis, IL-10 secretion has been shown to be detrimental to infection with cutaneous strains such as L. major, Leishmania mexicana, and Leishmania amazonensis (6, 7, (35) (36) (37) , and to the visceral strain Leishmania donovani (38 -40) . The dependence on IL-10 in determining disease outcome may also depend on the particular substrain of L. major, as has been documented with L. major LV39 (6) and L. major Seidman (35) . The mechanisms of induction and the cellular sources of IL-10 during infection are of considerable interest. In leishmaniasis, IL-10 may be secreted by conventional CD4
ϩ T effector cells, CD4 ϩ C25 ϩ Treg cells (17) , dendritic cells (41), and macrophages via FcR cross-linking (7, 42) .
There has been recent attention given to CD4 ϩ CD25 ϩ Treg cells in the pathogenesis of leishmaniasis and infectious diseases in general (43) . There is not an overall consensus on what the function of natural Treg cells may be in L. major infection, and disparate experimental outcomes have frustrated attempts at creating a unifying model to explain L. major susceptibility. In L. majorresistant C57BL/6 mice, Belkaid et al. (17, 44) have shown that the IL-10-secreting CD4 ϩ CD25 ϩ Treg function to maintain chronic infection to L. major/Friedlin and may be required to maintain immunological memory. Further studies showed that these cells maintain a Foxp3 ϩ phenotype and recognize L. major Ags presented by infected dendritic cells (45) . Anderson et al. (35) showed that CD4 ϩ CD25 ϩ T cells promote susceptibility in C57BL/6 mice chronically infected with L. major NIH/Seidman substrain, but recently found that the CD4 ϩ CD25 Ϫ Foxp3 Ϫ population was responsible for IL-10-mediated susceptibility (22 mice provide a useful model for elucidating the mechanisms of IL-10-mediated susceptibility in L. major infection. In these mice, IL-10 is the exclusive factor that promotes L. major LV39 parasite growth. Consistent with our previous findings in footpad infections (6), we show that in the ear dermis infection model, IL-4R␣
Ϫ/Ϫ mice depleted of IL-10 activity, either by anti-IL-10R mAb or by IL-10 gene deletion, are fully resistant to L. major LV39 (Fig. 2) .
The results of T cell transfers shown in Fig. 4 also strongly suggest that CD4 ϩ T cells are driving IL-10 responses in IL-4R␣ Ϫ/Ϫ mice, because naive CD4 ϩ T cells isolated from either IL-4R␣ Ϫ/Ϫ (susceptible) or IL-4R␣ ϫ IL-10 (resistant) mouse strains transferred their respective disease outcomes to IL-4R␣ ϫ RAG2 mice. In previous experiments, we also found that IL-4R␣ Ϫ/Ϫ mice exhibited a healing phenotype after anti-CD4 mAb treatment at the time of infection (6).
Although T cell-derived IL-10 is critical for L. major parasite growth in IL-4R␣ Ϫ/Ϫ mice, the source of IL-10 is not confined to CD4 ϩ CD25 ϩ Treg cells, as shown by comparing disease outcomes after anti-CD25 and anti-IL-10R mAb treatments in vivo, adoptive transfer of CD25-depleted CD4 ϩ T cells into IL-4R␣ ϫ RAG2 KO mice, intracellular IL-10 and Foxp3 FACS analysis, and qPCR (Figs. 2, 4, 6, and 7) . Indeed, a majority of IL-10 is secreted by CD4 ϩ Foxp3 Ϫ T cells in the dermis (Fig. 6) . We have not, however, dismissed a role for Treg cells in promoting L. major susceptibility. Infected IL-4R␣ Ϫ/Ϫ mice consistently displayed a 1.5-to 2-fold increase in CD4 ϩ Foxp3 ϩ Treg cells within the dermal site accompanied with suppressed IFN-␥ responses compared with BALB/c mice (Figs. 5 and 6) .
Based on the data, we propose a model of L. major susceptibility that is biased toward (Fig. 6) , the IL-10-producing CD4 ϩ T cells are distinct from the IL-10/IFN-␥-secreting Th1 cells recently described in C57BL/6 mice infected with L. major Seidman (22) or in another intracellular parasite infection with Toxoplasma gondii (47) . Our attempts to characterize the IL-10 producers as Th2 cells were not fruitful because it was difficult to enumerate IL-4-producing cells within the dermal site by FACS analysis (Fig.  8) , and the Th2-specific transcription factor GATA3 was found in all CD25 ϩ/Ϫ -and CD103 ϩ/Ϫ -sorted CD4 ϩ populations from BALB/c and IL-4R␣ Ϫ/Ϫ dermis and LN (data not shown). Nonetheless, in the draining LN where IL-4 was detected, there were very few CD4 ϩ cells that secreted both IL-10 and IL-4 ( Fig. 8) , suggesting that these are not Th2 cells.
Although the role of IL-10 in susceptibility of IL-4R␣ Ϫ/Ϫ mice is unequivocal, the increase in Treg cells in the IL-4R␣ Ϫ/Ϫ dermis compels us to speculate that Treg may suppress local IFN-␥ responses through IL-10-independent mechanisms. This is supported by data from Foussat et al. (48) , in which CD4 ϩ CD45RB low cells, known to contain Treg cells, did not produce IL-10 themselves, but nevertheless suppressed inflammation indirectly by differentiating Tr1 cells to secrete IL-10. In recently described experimental Schistosoma mansoni infections, the Treg population was also found to direct the development of T effector responses to S. mansoni parasite eggs in an IL-10-independent fashion (49) .
Alternatively, Treg cells may induce suppression by direct cell contact with effector Th1 cells, by altering APC function, or by TGF-␤ secretion (50) . Although TGF-␤ has been noted in L. major disease progression (20), we and others have shown through gene deletion that the cytokines IL-4, IL-13, and IL-10 are predominate susceptibility factors in L. major LV39 infection (2, 3, 6, 51) . The results of anti-IL-10 mAb-treated IL-4R␣ Ϫ/Ϫ mice and infections in IL-4R␣ ϫ IL-10 mice support this conclusion (Figs. 2 and 4) .
The increased percentage of CD4
ϩ Foxp3 ϩ T cells in the IL-4R␣ Ϫ/Ϫ dermis may be due to their retention in the infection site as a consequence of impaired IL-4/IL-13 signaling on T cells themselves or on non-T cells such as dendritic cells or macrophages, which are host cells for L. major infection. Because IL-4R␣ ϫ IL-10 mice are highly resistant to L. major, despite reduced numbers of dermal CD4 ϩ Foxp3 ϩ T cells (Fig. 5 ) and low percentages of IFN-␥-secreting CD4 ϩ T cells (Fig. 6C) , we favor the hypothesis that the IL-4R␣ deficiency promotes a retention or recruitment of Treg cells to the site, due to chronic Ag stimulation or stimulatory signals from infected APCs. Once the infection has cleared, as in the case of resistant IL-4R␣ ϫ IL-10 mice, the CD4 ϩ Foxp3 ϩ T cells are no longer retained within the site. Interestingly, Yao et al. (52) have shown that dendritic cell production of IL-10 was inhibited by IL-4 signaling. In infection with L. donovani, a strain causing visceral leishmaniasis, splenic stromal cells were shown to promote the development of tolerogenic or regulatory dendritic cells that secreted IL-10 during this chronic infection (53) . The same group has recently shown that the majority of T cell-derived IL-10 is also secreted by CD4 ϩ
CD25
Ϫ Foxp3 Ϫ cells in L. donovani infection (54) . Because BALB/c and IL-4R␣ Ϫ/Ϫ mice have similar parasite loads ( Fig. 1) , it is unlikely that exposure to L. major alone can be attributed to the increased Foxp3 ϩ cells in the IL-4R␣ Ϫ/Ϫ dermis. We have, however, observed a pronounced increase in CD11b 
